Bal Pharma DMF, CEP, Written Confirmations, FDF, Prices, Patents, Patents & Exclusivities, Dossier, Manufacturer, Licensing, Distributer, Suppliers, News, GMP

Bal Pharma Consolidated June 2024 Net Sales at Rs 74.36 crore, up 5.64% Y-o-Y

23 Aug 2024

// MONEYCONTROL

Bal Pharma consolidated net profit rises 225.00% in the June 2024 quarter

13 Aug 2024

// BUSINESS-STANDARD

Karnataka pharma terms Union Budget as tepid with no mention of PLI scheme

24 Jul 2024

// PHARMABIZ

DATA COMPILATION
#PharmaFlow

Contact Supplier

Website

CPHI Middle east

Booth #A82

Book a meeting

envelop Contact Supplier

DIGITAL CONTENT

7 CORPORATE CONTENT #SupplierSpotlight, 13 NEWS #PharmaBuzz

media
7 CORPORATE CONTENT #SupplierSpotlight
13 NEWS #PharmaBuzz

ACTIVE PHARMA INGREDIENTS

31 All APIs, 2 USDMF, 5 CEP/COS, 4 JDMF, 10 EU WC, 7 KDMF, 27 Listed APIs

31 All APIs
2 USDMF
5 CEP/COS
4 JDMF
10 EU WC
7 KDMF
27 Listed APIs

DEVELOPMENTS

1 Drugs in Development

1 Drugs in Development

FINISHED DOSAGE FORMULATIONS

185 FDF Dossiers, 185 Listed Dossiers

185 FDF Dossiers
185 Listed Dossiers

KEY PRODUCTS

Adapalene, Amiloride Hydrochloride, Aripiprazole, Benzydamine Hydrochloride, Dabigatran Etexilate Mesylate, Deferasirox, Ebastine, Gliclazide, Prazosin Hydrochloride, Topiramate

Adapalene
Amiloride Hydrochloride
Aripiprazole
Benzydamine Hydrochloride
Dabigatran Etexilate Mesylate
Deferasirox
Ebastine
Gliclazide
Prazosin Hydrochloride
Topiramate

INSPECTIONS & REGISTRATIONS

2 FDA, 2 EDQM, 3 WHO-GMP, 1 GDUFA

inspections
2 FDA
2 EDQM
3 WHO-GMP
1 GDUFA

Bal Pharma, leading manufacturer of niche & specialty API, Intermediates and Finished Formulations.

About

Bal Pharma is a leading Indian pharmaceutical company with 30+ years of experience, specializing in prescription drugs, generic and OTC products, intravenous infusions, and bulk actives. We are dedicated to enhancing patients' quality of life by offering products that are safe, effective, high-quality, and affordable. Bal Pharma's APIs and FDFs are produced at world-class manufacturing facilities. Our APIs are widely exported to Europe, the Far East, Latin America, Africa, the Middle East, and other global markets. Our FDFs are exported to semi-regulated and non-regulated markets, and we are now entering regulated markets.